Microbot Medical Inc. (NASDAQ:MBOT) Short Interest Up 80.0% in December

by · The Cerbat Gem

Microbot Medical Inc. (NASDAQ:MBOTGet Free Report) was the target of a large growth in short interest in December. As of December 31st, there was short interest totalling 1,040,000 shares, a growth of 80.0% from the December 15th total of 577,700 shares. Based on an average daily trading volume, of 2,030,000 shares, the short-interest ratio is presently 0.5 days.

Microbot Medical Stock Performance

Microbot Medical stock traded down $0.14 during mid-day trading on Friday, reaching $1.65. The company’s stock had a trading volume of 2,136,073 shares, compared to its average volume of 11,616,517. The firm’s fifty day moving average price is $1.19 and its two-hundred day moving average price is $1.05. The company has a market capitalization of $33.29 million, a P/E ratio of -2.05 and a beta of 1.46. Microbot Medical has a 12-month low of $0.82 and a 12-month high of $3.38.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Microbot Medical stock. Thoroughbred Financial Services LLC purchased a new position in Microbot Medical Inc. (NASDAQ:MBOTFree Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 52,250 shares of the biotechnology company’s stock, valued at approximately $53,000. Thoroughbred Financial Services LLC owned about 0.33% of Microbot Medical as of its most recent SEC filing. 16.30% of the stock is currently owned by hedge funds and other institutional investors.

Microbot Medical Company Profile

(Get Free Report)

Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.

See Also